Leptin and adiponectin receptor expression in oesophageal cancer

British Journal of Surgery

Volumn 101, Issue 6, 2014, Pages 643-652

  Howard, J M ^a   Cathcart, M C ^a   Healy, L ^a   Beddy, P ^a   Muldoon, C ^a   Pidgeon, G P ^a   Reynolds, J V ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN RECEPTOR; ADIPOR1 PROTEIN, HUMAN; ADIPOR2 PROTEIN, HUMAN; LEPTIN RECEPTOR;

ABDOMINAL OBESITY; ADENOCARCINOMA; AGED; ARTICLE; ESOPHAGUS TUMOR; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MALE; METABOLISM; MORTALITY; REGRESSION ANALYSIS; SQUAMOUS CELL CARCINOMA; TISSUE MICROARRAY;

ADENOCARCINOMA; AGED; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; OBESITY, ABDOMINAL; RECEPTORS, ADIPONECTIN; RECEPTORS, LEPTIN; REGRESSION ANALYSIS; TISSUE ARRAY ANALYSIS;

EID: 84898546756     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.9469     Document Type: Article

References (47)

1. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ,. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348: 1625-1638.
2. Pischon T, Nöthlings U, Boeing H,. Obesity and cancer. Proc Nutr Soc 2008; 67: 128-145.
3. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M,. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008; 371: 569-578.
4. Cook MB, Greenwood DC, Hardie LJ, Wild CP, Forman D,. A systematic review and meta-analysis of the risk of increasing adiposity on Barrett's esophagus. Am J Gastroenterol 2008; 103: 292-300.
5. Ryan AM, Healy LA, Power DG, Byrne M, Murphy S, Byrne PJ, et-al. Barrett esophagus: prevalence of central adiposity, metabolic syndrome, and a proinflammatory state. Ann Surg 2008; 247: 909-915.
6. Beddy P, Howard J, McMahon C, Knox M, de Blacam C, Ravi N, et-al. Association of visceral adiposity with oesophageal and junctional adenocarcinomas. Br J Surg 2010; 97: 1028-1034.
7. MacInnis RJ, English DR, Hopper JL, Giles GG,. Body size and composition and the risk of gastric and oesophageal adenocarcinoma. Int J Cancer 2006; 118: 2628-2631.
8. Steffen A, Schulze MB, Pischon T, Dietrich T, Molina E, Chirlaque MD, et-al. Anthropometry and esophageal cancer risk in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev 2009; 18: 2079-2089.
9. Dalamaga M, Diakopoulos KN, Mantzoros CS,. The role of adiponectin in cancer: a review of current evidence. Endocr Rev 2012; 33: 547-594.
10. Howard JM, Pidgeon GP, Reynolds JV,. Leptin and gastro-intestinal malignancies. Obes Rev 2010; 11: 863-874.
11. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, et-al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1995; 1: 1155-1161.
12. Ogunwobi OO, Beales IL,. Leptin stimulates the proliferation of human oesophageal adenocarcinoma cells via HB-EGF and TGFalpha mediated transactivation of the epidermal growth factor receptor. Br J Biomed Sci 2008; 65: 121-127.
13. Somasundar P, Riggs D, Jackson B, Vona-Davis L, McFadden DW,. Leptin stimulates esophageal adenocarcinoma growth by nonapoptotic mechanisms. Am J Surg 2003; 186: 575-578.
14. Nishida M, Funahashi T, Shimomura I,. Pathophysiological significance of adiponectin. Med Mol Morphol 2007; 40: 55-67.
15. Kadowaki T, Yamauchi T,. Adiponectin and adiponectin receptors. Endocr Rev 2005; 26: 439-451.
16. Kelesidis I, Kelesidis T, Mantzoros CS,. Adiponectin and cancer: a systematic review. Br J Cancer 2006; 94: 1221-1225.
17. Konturek PC, Burnat G, Rau T, Hahn EG, Konturek S,. Effect of adiponectin and ghrelin on apoptosis of Barrett adenocarcinoma cell line. Dig Dis Sci 2008; 53: 597-605.
18. Ogunwobi OO, Beales IL,. Globular adiponectin, acting via adiponectin receptor-1, inhibits leptin-stimulated oesophageal adenocarcinoma cell proliferation. Mol Cell Endocrinol 2008; 285: 43-50.
19. Yildirim A, Bilici M, Cayir K, Yanmaz V, Yildirim S, Tekin SB,. Serum adiponectin levels in patients with esophageal cancer. Jpn J Clin Oncol 2009; 39: 92-96.
20. Ishikawa M, Kitayama J, Kazama S, Hiramatsu T, Hatano K, Nagawa H,. Plasma adiponectin and gastric cancer. Clin Cancer Res 2005; 11 (Pt 1): 466-472.
21. Rubenstein JH, Kao JY, Madanick RD, Zhang M, Wang M, Spacek MB, et-al. Association of adiponectin multimers with Barrett's esophagus. Gut 2009; 58: 1583-1589.
22. Howard JM, Beddy P, Ennis D, Keogan M, Pidgeon GP, Reynolds JV,. Associations between leptin and adiponectin receptor upregulation, visceral obesity and tumour stage in oesophageal and junctional adenocarcinoma. Br J Surg 2010; 97: 1020-1027.
23. Otani K, Kitayama J, Kamei T, Soma D, Miyato H, Yamauchi T, et-al. Adiponectin receptors are downregulated in human gastric cancer. J Gastroenterol 2010; 45: 918-927.
24. Tsukada T, Fushida S, Harada S, Terai S, Yagi Y, Kinoshita J, et-al. Adiponectin receptor-1 expression is associated with good prognosis in gastric cancer. J Exp Clin Cancer Res 2011; 30: 107.
25. Barresi V, Grosso M, Giuffrè G, Tuccari G, Barresi G,. The expression of adiponectin receptors Adipo-R1 and Adipo-R2 is associated with an intestinal histotype and longer survival in gastric carcinoma. J Clin Pathol 2009; 62: 705-709.
26. Ishikawa M, Kitayama J, Yamauchi T, Kadowaki T, Maki T, Miyato H, et-al. Adiponectin inhibits the growth and peritoneal metastasis of gastric cancer through its specific membrane receptors AdipoR1 and AdipoR2. Cancer Sci 2007; 98: 1120-1127.
27. Yoneda K, Tomimoto A, Endo H, Iida H, Sugiyama M, Takahashi H, et-al. Expression of adiponectin receptors, AdipoR1 and AdipoR2, in normal colon epithelium and colon cancer tissue. Oncol Rep 2008; 20: 479-483.
28. Byeon JS, Jeong JY, Kim MJ, Lee SM, Nam WH, Myung SJ, et-al. Adiponectin and adiponectin receptor in relation to colorectal cancer progression. Int J Cancer 2010; 127: 2758-2767.
29. Williams CJ, Mitsiades N, Sozopoulos E, Hsi A, Wolk A, Nifli AP, et-al. Adiponectin receptor expression is elevated in colorectal carcinomas but not in gastrointestinal stromal tumors. Endocr Relat Cancer 2008; 15: 289-299.
30. Hiyoshi M, Tsuno NH, Otani K, Kawai K, Nishikawa T, Shuno Y, et-al. Adiponectin receptor 2 is negatively associated with lymph node metastasis of colorectal cancer. Oncol Lett 2012; 3: 756-760.
31. Wang QY, Shen ZX,. The expression and value of leptin and leptin receptor in human esophageal carcinoma. LabMedicine 2012; 43: 1-5.
32. Rice TW, Blackstone EH, Rusch VW,. 7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction. Ann Surg Oncol 2010; 17: 1721-1724.
33. Ennis DP, Pidgeon GP, Millar N, Ravi N, Reynolds JV,. Building a bioresource for esophageal research: lessons from the early experience of an academic medical center. Dis Esophagus 2009; 23: 1-7.
34. Baumgartner RN, Heymsfield SB, Roche AF, Bernardino M,. Abdominal composition quantified by computed tomography. Am J Clin Nutr 1988; 48: 936-945.
35. Doyle SL, Bennett AM, Donohoe CL, Mongan AM, Howard JM, Lithander FE, et-al. Establishing computed tomography-defined visceral fat area thresholds for use in obesity-related cancer research. Nutr Res 2013; 33: 171-179.
36. Paik SS, Jang SM, Jang KS, Lee KH, Choi D, Jang SJ,. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma. Ann Surg Oncol 2009; 16: 297-303.
37. Donohoe CL, Doyle SL, McGarrigle S, Cathcart MC, Daly E, O'Grady A, et-al. Role of the insulin-like growth factor 1 axis and visceral adiposity in oesophageal adenocarcinoma. Br J Surg 2012; 99: 387-396.
38. Hong SJ, Kwon KW, Kim SG, Ko BM, Ryu CB, Kim YS, et-al. Variation in expression of gastric leptin according to differentiation and growth pattern in gastric adenocarcinoma. Cytokine 2006; 33: 66-71.
39. Ishikawa M, Kitayama J, Nagawa H,. Expression pattern of leptin and leptin receptor (OB-R) in human gastric cancer. World J Gastroenterol 2006; 12: 5517-5522.
40. Zhao X, Huang K, Zhu Z, Chen S, Hu R,. Correlation between expression of leptin and clinicopathological features and prognosis in patients with gastric cancer. J Gastroenterol Hepatol 2007; 22: 1317-1321.
41. Koda M, Sulkowska M, Kanczuga-Koda L, Surmacz E, Sulkowski S,. Overexpression of the obesity hormone leptin in human colorectal cancer. J Clin Pathol 2007; 60: 902-906.
42. Uddin S, Bavi PP, Hussain AR, Alsbeih G, Al-Sanea N, Abduljabbar A, et-al. Leptin receptor expression in Middle Eastern colorectal cancer and its potential clinical implication. Carcinogenesis 2009; 30: 1832-1840.
43. Aloulou N, Bastuji-Garin S, Le Gouvello S, Abolhassani M, Chaumette MT, Charachon A, et-al. Involvement of the leptin receptor in the immune response in intestinal cancer. Cancer Res 2008; 68: 9413-9422.
44. Wang SN, Chuang SC, Yeh YT, Yang SF, Chai CY, Chen WT, et-al. Potential prognostic value of leptin receptor in hepatocellular carcinoma. J Clin Pathol 2006; 59: 1267-1271.
45. Jeong YJ, Bong JG, Park SH, Choi JH, Oh HK,. Expression of leptin, leptin receptor, adiponectin, and adiponectin receptor in ductal carcinoma in situ and invasive breast cancer. J Breast Cancer 2011; 14: 96-103.
46. Abdul-Ghafar J, Oh SS, Park SM, Wairagu P, Lee SN, Jeong Y, et-al. Expression of adiponectin receptor 1 is indicative of favorable prognosis in non-small cell lung carcinoma. Tohoku J Exp Med 2013; 229: 153-162.
47. Denzel MS, Hebbard LW, Shostak G, Shapiro L, Cardiff RD, Ranscht B,. Adiponectin deficiency limits tumor vascularization in the MMTV-PyV-mT mouse model of mammary cancer. Clin Cancer Res 2009; 15: 3256-3264.